scispace - formally typeset
I

Isaac Sinay

Researcher at Cardiovascular Institute of the South

Publications -  7
Citations -  2260

Isaac Sinay is an academic researcher from Cardiovascular Institute of the South. The author has contributed to research in topics: Diabetes mellitus & Hazard ratio. The author has an hindex of 4, co-authored 6 publications receiving 1841 citations. Previous affiliations of Isaac Sinay include University of Buenos Aires.

Papers
More filters
Journal ArticleDOI

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, +798 more
- 27 Oct 2018 - 
TL;DR: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events, and evidence-based glucagon-like peptide 1 receptor agonists should be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events.
Journal ArticleDOI

Effect of valsartan on the incidence of diabetes and cardiovascular events.

John J.V. McMurray, +53 more
TL;DR: Among patients with impaired glucose tolerance and cardiovascular disease or risk factors, the use of valsartan for 5 years, along with lifestyle modification, led to a relative reduction of 14% in the incidence of diabetes but did not reduce the rate of cardiovascular events.
Journal ArticleDOI

Effect of nateglinide on the incidence of diabetes and cardiovascular events

Rury R. Holman, +56 more
TL;DR: Among persons with impaired glucose tolerance and established cardiovascular disease or cardiovascular risk factors, assignment to nateglinide for 5 years did not reduce the incidence of diabetes or the coprimary composite cardiovascular outcomes.